The Department of the Army Medical Command is seeking to procure 18 units of Polyserp Snake (Mena) Antivenom 6S, a specialized polyvalent antivenom designed to treat bites from 27 species of Middle Eastern, North African, and Central Asian snakes from the Elapidae and Viperidae families. The U.S. Army Medical Materiel Center Europe (USAMMCE) requires this antivenom to be licensed for human use, freeze-dried for field deployment, and stable at temperatures up to 40°C for six months without refrigeration. The antivenom must be suitable for direct intravenous administration in low-resource environments, making it critical for military medical operations in challenging conditions. The solicitation will be evaluated using lowest price technically acceptable criteria on a firm fixed price basis. Quotes are due by August 29, 2025, at 12:00 PM, with no indication of a separate deadline for questions.

This procurement is designated as a Women-Owned Small Business (WOSB) set-aside under NAICS code 339112 for Surgical and Medical Instrument Manufacturing. No incumbent contractors or current service providers are mentioned in the solicitation documents. While specific award values or budget ranges are not disclosed, the relatively small quantity of 18 units suggests a focused procurement for specialized military medical readiness. The contract requires delivery within 45 calendar days from the date of award. Performance will take place at the USAMMCE Distribution and Transportation Division in Kaiserslautern, Germany, with the broader place of performance listed as Landstuhl, Germany.

Antivenom

Opportunity facts

About this opportunity

Notice text

Files

Work this opportunity